2024-512448-41-00
CTIS ↗
Liposomal Ciclosporin A, Liposomal Ciclosporin A
Bronchiolitis Obliterans Syndrome in Patients post Single or post Double Lung Transplantation
pharma · Motor fluctuations in advanced Parkinson’s disease · Non Cystic Fibrosis Bronchiectasis
ZAMBON S.P.A
Zambon SpA
ZAMBON S.P.A trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.
IT HQ
8 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- IT
- Employees
- 8
- Programs
- 3
- Drugs
- 7
- Patents
- 0
ZAMBON S.P.A clinical trials
Registry index of 3 ClinicalTrials.gov studies linked to ZAMBON S.P.A programs — each row shows trial ID, program name, phase, status, and indication.
ZAMBON S.P.A trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for ZAMBON S.P.A.